Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:28 PM
Ignite Modification Date:
2025-12-24 @ 1:28 PM
NCT ID:
NCT01844895
Eligibility Criteria:
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com
Inclusion Criteria:
* Subjects who have been treated in the long term (LT) with open-label SC Abatacept for at least 3 months
* Must continue to meet inclusion criteria specified in main IM101-174 Study Protocol
Exclusion Criteria:
* Participation in previous device substudy (implemented by Amendment 10)
* Must continue to meet exclusion criteria specified in main IM101-174 Study Protocol
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01844895
Study Brief:
Protocol Section:
NCT01844895